NHS research proves conclusively that our product is successful in dealing with morning sickness for over 90%.
Motion Sickness Clinical Trial
The MRC Spatial Disorientation Group - Imperial College of medicine, Westminster, London proves our programme highly successful against Travel Sickness.
HONcode Compliance.
This site complies with the HONcode standard for trustworthy health information:
verify here.
Who has researched
Nevasic?
Clinical trial -
Motion sickness
The MRC Spatial Disorientation Group, Imperial College School of Medicine, London ran a full clinical trial under the branded of TravelWell.
The trial proved conclusively that the programme is highly effective in combating the symptoms of nausea and vomiting associated with motion sickness.
The report from the trial is lodged with PubMed and available via the National Library of Medicine (USA).
Here is the abstract report:
1: J Travel Med. 2003 Mar-Apr,10(2):108-11 Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA. The MRC Spatial Disorientation Group, Imperial College School of Medicine, London, United Kingdom.
BACKGROUND: Behavioral countermeasures for motion sickness would be advantageous because of the side effects of antiemetic drugs, but few alternatives treatments are available. The objective of this study was to compare the effectiveness of controlling breathing and listening to a music audiotape designed to reduce motion sickness symptoms, on increasing tolerance to motion sickness.
METHOD: Twenty-four healthy subjects were exposed to nauseogenic Coriolis stimulation on a rotating turntable under three conditions: whilst focusing on controlling breathing; listening to a music audiotape; or without intervention (control). The three conditions were performed by each subject according to a replicated factorial design at 1-week intervals at the same time of day. Ratings of motion sickness were obtained every 30 seconds. Once a level of mild nausea was reached subjects commenced controlling breathing or listened to the music audiotape. Motion was stopped after the onset of moderate nausea.
RESULTS: Mean (+/- SD) motion exposure time in minutes tolerated before the onset of moderate nausea was significantly longer (p <.01) for controlling breathing (10.7 +/- 5.6 min) and longer (p <.01) for music (10.4 +/- 5.6 min) compared with control (9.2 +/- 5.9 min).
CONCLUSIONS: Both controlling breathing and the music audiotape provided significant protection against motion sickness. They are easy to implement and free of side effects.
Publication Types: Clinical Trial Controlled Clinical Trial
PMID: 12650654 [PubMed - indexed for MEDLINE] Click the below line or copy and paste it to your address bar to view this information direct within the pages of PubMed (United States National Library Of Medicine: http://www.ncbi.nlm.nih.gov
The report was published by the International Society of Travel Medicine (http://www.istm.org/). To obtain the correct report quote "Journal of Travel Medicine Volume: 10 • Issue: 02 • 2003 • March • Page: 108"
NHS study -
Morning sickness
Nevasic was studied by the UK NHS under the branded name of MorningWell.
The study was commissioned by;
Mr M J Heard FRCOG
Department of Obstetrics and
Gynaecology
Royal Hampshire County
Hospital
Winchester, UK.
Study Manager;
Midwife Mrs Lynne Mayo - SRN, SCM, - Andover NHS Birth Centre.
NHS research data.
A National Health Service (NHS) Study showed 9 out of 10 pregnant women experienced a reduction or elimination of their symptoms of nausea & vomiting in morning sickness by using Nevasic branded as MorningWell. If you prefer to buy MorningWell please visit http://www.morningwell.co.uk.
As a result of the study MorningWell is still available as a CD and is distributed in the UK by The National Childbirth Trust. As MorningWell is derived of Nevasic technology - you can gain the same benefits by using Nevasic.
